OptumRx has published its quarterly Drug Pipeline Insights Report, which highlights three notable drugs that could have a significant impact on payers and patients. The drugs are currently being ...

Penn State alleges it has been overcharged millions of dollars since 2008.

Health plan trustees at a Minneapolis-based construction workers union are suing a subsidiary of UnitedHealth Group for paying more than $4 million for costly weight-loss drugs, depleting union funds ...

OptumRx, the pharmacy benefit management subsidiary of Minnetonka, Minn.-based UnitedHealth Group, won a bid to manage New Jersey’s roughly $2 billion drug benefit program for state employees. OptumRx ...

UnitedHealth Group, Inc’s. UNH Optum Rx is expanding its offerings for patients with the introduction of two additional HUMIRA biosimilars. Effective Jul 1, Optum Rx will offer three biosimilar ...

Penn State sues insulin makers and PBMs alleging inflated prices and seeks damages for overpayments in its self-insured health plans.

OptumRx is paying $20 million to settle allegations the company broke federal law by mailing opioids alongside other medications without resolving red flags about whether they were for legitimate ...

The man's family later sued OptumRx and Walgreens, claiming they didn't offer alternatives after his regular inhaler's price increased dramatically.

UnitedHealth Group remains a Buy, downgraded from Strong Buy, due to new industry headwinds and recent stock appreciation. Potential disruption from TrumpRx could significantly impact OptumRx’s ...

The motion to dismiss was requested by Optum Rx, a subsidiary of United Health Group.